|
1
|
Ellis SL, Grassinger J, Jones A, Borg J,
Camenisch T, Haylock D, Bertoncello I and Nilsson SK: The
relationship between bone, hemopoietic stem cells, and vasculature.
Blood. 118:1516–1524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Felix R, Elford PR, Stoercklé C, Cecchini
M, Wetterwald A, Trechsel U, Fleisch H and Stadler BM: Production
of hemopoietic growth factors by bone tissue and bone cells in
culture. J Bone Miner Res. 3:27–36. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guntur AR and Rosen CJ: Bone as an
endocrine organ. Endocr Pract. 18:758–762. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cianferotti L and Brandi ML: Muscle-bone
interactions: Basic and clinical aspects. Endocrine. 45:165–177.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rendina E, Hembree KD, Davis MR, Marlow D,
Clarke SL, Halloran BP, Lucas EA and Smith BJ: Dried plum's unique
capacity to reverse bone loss and alter bone metabolism in
postmenopausal osteoporosis model. PLoS One. 8:e605692013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Faienza MF, Ventura A, Marzano F and
Cavallo L: Postmenopausal osteoporosis: The role of immune system
cells. Clin Dev Immunol. 2013:5759362013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Armas LA and Recker RR: Pathophysiology of
osteoporosis: New mechanistic insights. Endocrinol Metab Clin North
Am. 41:475–486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rachner TD, Khosla S and Hofbauer LC:
Osteoporosis: Now and the future. Lancet. 377:1276–1287. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Charles JF and Aliprantis AO: Osteoclasts:
More than ‘bone eaters’. Trends Mol Med. 20:449–459. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clarke BL and Khosla S: Androgens and
bone. Steroids. 74:296–305. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gallagher JC and Tella SH: Prevention and
treatment of postmenopausal osteoporosis. J Steroid Biochem Mol
Biol. 142:155–170. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jackson RD and Mysiw WJ: Insights into the
epidemiology of postmenopausal osteoporosis: The women's health
initiative. Semin Reprod Med. 32:454–462. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bowring CE and Francis RM: National
Osteoporosis Society's position statement on hormone replacement
therapy in the prevention and treatment of osteoporosis. Menopause
Int. 17:63–65. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tirabassi G, Biagioli A and Balercia G:
Bone benefits of testosterone replacement therapy in male
hypogonadism. Panminerva Med. 56:151–163. 2014.PubMed/NCBI
|
|
15
|
Cartwright B, Robinson J, Seed PT,
Fogelman I and Rymer J: Hormone replacement therapy versus the
combined oral contraceptive pill in premature ovarian failure: A
randomized controlled trial of the effects on bone mineral density.
J Clin Endocrinol Metab. 101:3497–3505. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jo DG, Lee HS, Joo YM and Seo JT: Effect
of testosterone replacement therapy on bone mineral density in
patients with Klinefelter syndrome. Yonsei Med J. 54:1331–1335.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kasperk CH, Wergedal JE, Farley JR,
Linkhart TA, Turner RT and Baylink DJ: Androgens directly stimulate
proliferation of bone cells in vitro. Endocrinology. 124:1576–1578.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Drake MT and Khosla S: Male osteoporosis.
Endocrinol Metab Clin North Am. 41:629–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Swartz CM and Young MA: Male hypogonadism
and bone fracture. N Engl J Med. 318:9961988. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nieminen MS, Rämö MP, Viitasalo M,
Heikkilä P, Karjalainen J, Mäntysaari M and Heikkilä J: Serious
cardiovascular side effects of large doses of anabolic steroids in
weight lifters. Eur Heart J. 17:1576–1583. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lamb DR: Anabolic steroids in athletics:
How well do they work and how dangerous are they? Am J Sports Med.
12:31–38. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bassil N, Alkaade S and Morley JE: The
benefits and risks of testosterone replacement therapy: A review.
Ther Clin Risk Manag. 5:427–448. 2009.PubMed/NCBI
|
|
23
|
Frick KM, Kim J, Tuscher JJ and Fortress
AM: Sex steroid hormones matter for learning and memory: Estrogenic
regulation of hippocampal function in male and female rodents.
Learn Mem. 22:472–493. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Devlin TM: Textbook of biochemistry: With
clinical correlations. 7th. Hoboken; New Jersey: 2010
|
|
25
|
Kaminski RM, Marini H, Kim WJ and Rogawski
MA: Anticonvulsant activity of androsterone and etiocholanolone.
Epilepsia. 46:819–827. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Motofei IG: A dual physiological character
for cerebral mechanisms of sexuality and cognition: Common somatic
peripheral afferents. BJU Int. 108:1634–1639. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gruyter WD: Concise encyclopedia biology.
Berlin: 1996
|
|
28
|
Marques DRC, Marques D, Ibanez JF, Freitas
IB, Hespanha AC, Monteiro JF, Eggert M and Becker A: Effects of
nandrolone decanoate on time to consolidation of bone defects
resulting from osteotomy for tibial tuberosity advancement. Vet
Comp Orthop Traumatol. 30:351–356. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nawata H, Tanaka S, Tanaka S, Takayanagi
R, Sakai Y, Yanase T, Ikuyama S and Haji M: Aromatase in bone cell:
Association with osteoporosis in postmenopausal women. J Steroid
Biochem Mol Biol. 53:165–174. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
da Costa KJ, Passos JJ, Gomes AD,
Sinisterra RD, Lanza CR and Cortés ME: Effect of testosterone
incorporation on cell proliferation and differentiation for
polymer-bioceramic composites. J Mater Sci Mater Med. 23:2751–2759.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zoch ML, Clemens TL and Riddle RC: New
insights into the biology of osteocalcin. Bone. 82:42–49. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tuck SP and Francis RM: Testosterone, bone
and osteoporosis. Front Horm Res. 37:123–132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Weinstein RS, Jilka RL, Parfitt AM and
Manolagas SC: The effects of androgen deficiency on murine bone
remodeling and bone mineral density are mediated via cells of the
osteoblastic lineage. Endocrinology. 138:4013–4021. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Diamond TH, Higano CS, Smith MR, Guise TA
and Singer FR: Osteoporosis in men with prostate carcinoma
receiving androgen-deprivation therapy: Recommendations for
diagnosis and therapies. Cancer. 100:892–899. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Daniell HW, Dunn SR, Ferguson DW, Lomas G,
Niazi Z and Stratte PT: Progressive osteoporosis during androgen
deprivation therapy for prostate cancer. J Urol. 163:181–186. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sessa G and Weissmann G: Differential
effecs of etiocholanolone on phospholipid/cholesterol structures
containing either testosterone or estradiol. Biochim Biophys Acta.
150:173–180. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Novak FJ and Lambert JG: Pregnenolone,
testosterone, and estradiol in the migratory locust
Locustamigratoria; a gas chromatographical-mass spectrometrical
study. Gen Comp Endocrinol. 76:73–82. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Penning TM, Burczynski ME, Jez JM, Hung
CF, Lin HK, Ma H, Moore M, Palackal N and Ratnam K: Human
3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the
aldo-keto reductase superfamily: functional plasticity and tissue
distribution reveals roles in the inactivation and formation of
male and female sex hormones. Biochem J. 351:67–77. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kamrath C, Hochberg Z, Hartmann MF, Remer
T and Wudy SA: Increased activation of the alternative ‘backdoor’
pathway in patients with 21-hydroxylase deficiency: Evidence from
urinary steroid hormone analysis. J Clin Endocrinol Metab.
97:E367–E375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tsitsimpikou C, Vasilaki F, Tsarouhas K,
Fragkiadaki P, Tzardi M, Goutzourelas N, Nepka C, Kalogeraki A,
Heretis I, Epitropaki Z, et al: Nephrotoxicity in rabbits after
long-term nandrolone decanoate administration. Toxicol Lett.
259:21–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Belardin LB, Simão VA, Leite GA, Chuffa LG
and Camargo IC: Dose-dependent effects and reversibility of the
injuries caused by nandrolone decanoate in uterine tissue and
fertility of rats. Birth Defects Res B Dev Reprod Toxicol.
101:168–177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
The biological properties of
etiocholanolone, . Combined clinical staff conference at the
National Institutes of Health. Ann Intern Med. 67:1268–1295. 1967.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kaminski RM, Marini H, Kim WJ and Rogawski
MA: Anticonvulsant activity of androsterone and etiocholanolone.
Epilepsia. 46:819–827. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Roux BM, Akar B, Zhou W, Stojkova K,
Barrera B, Brankov JG and Brey EM: Preformed vascular networks
survive and enhance vascularization in critical sized cranial
defectsTissue Eng Part A. 2018, View Article : Google Scholar : (Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pirraco RP, Iwata T, Yoshida T, Marques
AP, Yamato M, Reis RL and Okano T: Endothelial cells enhance the in
vivo bone-forming ability of osteogenic cell sheets. Lab Invest.
94:663–673. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cai J, Hong Y, Weng C, Tan C,
Imperato-McGinley J and Zhu YS: Androgen stimulates endothelial
cell proliferation via an androgen receptor/VEGF/cyclin A-mediated
mechanism. Am J Physiol Heart Circ Physiol. 300:H1210–H1221. 2011.
View Article : Google Scholar : PubMed/NCBI
|
